Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis
Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis
复制标题
DOI:
10.1093/rheumatology/keq105
复制
发表时间:
2010-07-01
期刊:
影响因子:
5.5
通讯作者:
Gladman, Dafna D.
中科院分区:
文献类型:
--
作者:
Chandran, Vinod;Cook, Richard J.;Gladman, Dafna D.
Objective. Biomarkers may be helpful in screening patients with psoriasis for PsA. Our purpose was to identify serum biomarkers for psoriasis and PsA.Methods. Fifty-two patients with psoriasis (26 satisfying CASPAR classification criteria for PsA) and 26 healthy controls were recruited for our study. Patients with psoriasis and PsA were group matched for age, sex and psoriasis duration, whereas controls were matched for age and sex. Blood samples were drawn at the time of assessment and serum was analysed for the following: IL-12, IL-12p40, IL-17, TNF super family member 14 (TNFSF14), MMP-3, RANK ligand (RANKL), osteoprotegerin (OPG), cartilage oligomeric matrix protein (COMP), C-propeptide of Type II collagen (CPII), collagen fragment neoepitopes Col2-3/4(long) (mono) (C2C) and Col2-3/4(short) (C1-2C) and highly sensitive CRP (hsCRP). Data were analysed using logistic regression and receiver operating characteristic curves were plotted.Results. Fifty-two patients with psoriatic disease had a mean age of 46 years and psoriasis duration of 16.8 years. Compared with controls, increased serum levels of RANKL, TNFSF14, MMP-3 and COMP independently associated with psoriatic disease (P